ArticleCell death & disease2021

Nrf2 overexpression increases risk of high tumor mutation burden in acute myeloid leukemia by inhibiting MSH2.

Ping Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.